Diabetes - Type 1 Related News
Breakthrough study links Type 1 diabetes and Sjogren’s syndrome
MEDIA RELEASE:
22 Apr 2011
Garvan scientists have identified a new group of immune cells that for the first time directly link two autoimmune diseases, Type 1 diabetes and Sjogren’s syndrome. Autoimmune diseases arise when the body’s defences become overactive, and instead of attacking invading microbes, it starts to attack itself. In the case of Type 1 diabetes, the body attacks insulin-producing cells in the pancreas. In the case of Sjogren’s syndrome, it attacks its own salivary glands.
Potential anti-rejection drug for insulin cell transplantation
MEDIA RELEASE:
01 Mar 2011
Garvan scientists have developed a reagent with the potential to prevent rejection of transplanted insulin-producing cells into people with Type 1 diabetes – one of the most promising immunology developments in recent years.
The cell dance that can lead to Type 1 diabetes
MEDIA RELEASE:
26 Oct 2010
Australian scientists have moved a step closer to understanding how immune cells (B cells and T cells) come together in a perilous dance that leads to Type 1 diabetes.
Shane Grey wins award for diabetes research
07 Sep 2010
Garvan immunologist Dr Shane Grey has won the prestigious 2010 Juvenile Diabetes Research Foundation / Macquarie Group Foundation Diabetes Research Innovation Award for an Early Career Researcher.
The genetic fuse that may ignite Type 1 diabetes
MEDIA RELEASE:
20 Oct 2009
Garvan scientists have discovered that a tiny genetic irregularity, which boosts the expression of a key gene, may lead to the development of Type 1 diabetes. While there is no cure yet, prevention therapies are on the horizon, making the development of reliable screening tools critical. And that's where the current finding has promise.
Potential preventative therapy for Type 1 diabetes
MEDIA RELEASE:
29 Apr 2009
Immunology researchers at Garvan believe they may have found a preventative therapy for Type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.
Creating indestructible insulin-producing cells
MEDIA RELEASE:
14 Nov 2007
Dr Shane Grey, head of Garvan's Gene Therapy and Autoimmunity Group, has received $350,000 from the Juvenile Diabetes Research Foundation, as part of their Australian Islet Transplantation Program. The grant will help him genetically modify cells enabling them to defy the body's attempts to reject or kill them after transplant.
Grant paves way to finding potential cure for Type 1 diabetes
26 Sep 2007
Dr Shane Grey, head of Garvan’s Gene Therapy and Autoimmunity Group, has been awarded a $3 M Program Grant, a joint initiative between the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes Research Foundation (JDRF) in Australia. Dr Grey aims to improve the success rate of‘islet transplantation’, a potential cure for Type I diabetes.
Genes and disease
08 Jun 2007
News reports today detail the discovery of genetic regions that contribute to the risk of developing seven of the Western World's common diseases.
